#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA4305726	F	Anti-osteoporosis activity in C57BL/6 mouse bone marrow macrophages assessed as inhibition of M-CSF/RANKL-induced osteoclast differentiation supplemented with fresh medium containing compounds every 2 days for 5 measured post-last dose by TRAP staining based assay	Mus musculus	69	ALA4304759	cell-based format	Scientific Literature
2.	ALA4305727	F	Anti-osteoporosis activity in C57BL/6 mouse bone marrow macrophages assessed as inhibition of M-CSF/RANKL-induced osteoclast differentiation by measuring reduction in TRAcP gene expression at 0.1 uM supplemented with fresh medium containing compounds every 2 days for 5 by trizol-reagent based RT-PCR analysis	Mus musculus	1	ALA4304759	cell-based format	Scientific Literature
3.	ALA4305728	F	Anti-osteoporosis activity in C57BL/6 mouse bone marrow macrophages assessed as inhibition of M-CSF/RANKL-induced osteoclast differentiation by measuring reduction in c-FOS gene expression at 0.1 uM supplemented with fresh medium containing compounds every 2 days for 5 by trizol-reagent based RT-PCR analysis	Mus musculus	1	ALA4304759	cell-based format	Scientific Literature
4.	ALA4305729	F	Anti-osteoporosis activity in C57BL/6 mouse bone marrow macrophages assessed as inhibition of M-CSF/RANKL-induced osteoclast differentiation by measuring reduction in MMP9 gene expression at 0.1 uM supplemented with fresh medium containing compounds every 2 days for 5 by trizol-reagent based RT-PCR analysis	Mus musculus	1	ALA4304759	cell-based format	Scientific Literature
5.	ALA4305730	F	Anti-osteoporosis activity in C57BL/6 mouse bone marrow macrophages assessed as inhibition of M-CSF/RANKL-induced osteoclast differentiation by measuring reduction in NFATc1 gene expression at 0.1 uM supplemented with fresh medium containing compounds every 2 days for 5 by trizol-reagent based RT-PCR analysis	Mus musculus	1	ALA4304759	cell-based format	Scientific Literature
6.	ALA4305731	F	Anti-osteoporosis activity in C57BL/6 mouse bone marrow macrophages assessed as inhibition of M-CSF/RANKL-induced osteoclast differentiation by measuring reduction in hydroxyapatite resorption at 0.01 to 1 uM measured after 48 hrs by microscopic analysis	Mus musculus	1	ALA4304759	cell-based format	Scientific Literature
7.	ALA4305732	A	Osteogenic activity in mouse C3H10T1/2 cells assessed as effect on osteogenic medium-induced osteoblast differentiation by measuring calcium deposition at 0.1 to 10 uM after 14 days by alizarin red dye-based assay	Mus musculus	1	ALA4304759	cell-based format	Scientific Literature
8.	ALA4305733	A	Cytotoxicity against mouse C3H10T1/2 cells assessed as effect on cell viability at 0.1 to 100 uM measured after 48 to 72 hrs by CCK8 assay	Mus musculus	1	ALA4304759	cell-based format	Scientific Literature
9.	ALA4305734	F	Anti-osteoporosis activity in ovariectomized Sprague-Dawley rat assessed as reduction in femur bone mass loss at 10 mg/kg/day, po for 3 months measured post-last dose by micro-CT analysis	Rattus norvegicus	1	ALA4304759	organism-based format	Scientific Literature
10.	ALA4305735	F	Anti-osteoporosis activity in ovariectomized Sprague-Dawley rat assessed as femur bone mineral density loss at 10 mg/kg/day, po for 3 months measured post-last dose by dual energy X-ray absorptiometry (RVb = 19%)	Rattus norvegicus	1	ALA4304759	organism-based format	Scientific Literature
11.	ALA4305737	F	Anti-osteoporosis activity in ovariectomized Sprague-Dawley rat assessed as reduction in serum CTX1 level at 10 mg/kg/day, po for 3 months measured post-last dose	Rattus norvegicus	1	ALA4304759	organism-based format	Scientific Literature
12.	ALA4305738	F	Anti-osteoporosis activity in ovariectomized Sprague-Dawley rat assessed as reduction in serum osteocalcin level at 10 mg/kg/day, po for 3 months measured post-last dose	Rattus norvegicus	1	ALA4304759	organism-based format	Scientific Literature
13.	ALA4305739	F	Anti-osteoporosis activity in ovariectomized Sprague-Dawley rat assessed as reduction in serum PINP level at 10 mg/kg/day, po for 3 months measured post-last dose	Rattus norvegicus	1	ALA4304759	organism-based format	Scientific Literature
14.	ALA4305740	A	Effect on serum RANKL level in ovariectomized Sprague-Dawley rat at 10 mg/kg/day, po for 3 months measured post-last dose	Rattus norvegicus	1	ALA4304759	organism-based format	Scientific Literature
15.	ALA4305742	T	Toxicity in ovariectomized Sprague-Dawley rat assessed as effect on total cholesterol level at 10 mg/kg/day, po for 3 months measured post-last dose	Rattus norvegicus	1	ALA4304759	organism-based format	Scientific Literature
16.	ALA4305743	T	Toxicity in ovariectomized Sprague-Dawley rat assessed as effect on total triglyceride level at 10 mg/kg/day, po for 3 months measured post-last dose	Rattus norvegicus	1	ALA4304759	organism-based format	Scientific Literature
17.	ALA4305744	T	Toxicity in ovariectomized Sprague-Dawley rat assessed as effect on alanine aminotransferase level at 10 mg/kg/day, po for 3 months measured post-last dose	Rattus norvegicus	1	ALA4304759	organism-based format	Scientific Literature
18.	ALA4305745	T	Toxicity in ovariectomized Sprague-Dawley rat assessed as effect on aspartate transaminase level at 10 mg/kg/day, po for 3 months measured post-last dose	Rattus norvegicus	1	ALA4304759	organism-based format	Scientific Literature
19.	ALA4305746	T	Toxicity in ovariectomized Sprague-Dawley rat assessed as effect on alkaline phosphatase level at 10 mg/kg/day, po for 3 months measured post-last dose	Rattus norvegicus	1	ALA4304759	organism-based format	Scientific Literature
20.	ALA4305747	T	Toxicity in ovariectomized Sprague-Dawley rat assessed as effect on blood urea nitrogen level at 10 mg/kg/day, po for 3 months measured post-last dose	Rattus norvegicus	1	ALA4304759	organism-based format	Scientific Literature